Azenta, Inc. (AZTA) is a publicly traded Healthcare sector company. As of May 21, 2026, AZTA trades at $18.43 with a market cap of $748.55M and a P/E ratio of -4.85. AZTA moved +5.27% today. Year to date, AZTA is -48.06%; over the trailing twelve months it is -34.31%. Its 52-week range spans $15.93 to $55.64. Analyst consensus is strong buy with an average price target of $30.75. Rallies surfaces AZTA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded AZTA stock?
Recent politician trading activity in AZTA includes disclosures from Gilbert Cisneros, Gilbert Cisneros, and Josh Gottheimer. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
AZTA Key Metrics
Key financial metrics for AZTA
Metric
Value
Price
$18.43
Market Cap
$748.55M
P/E Ratio
-4.85
EPS
$-3.77
Dividend Yield
0.10%
52-Week High
$55.64
52-Week Low
$15.93
Volume
3.90K
Avg Volume
0
Revenue (TTM)
$596.48M
Net Income
$-173.34M
Gross Margin
44.33%
Congressional Trades in AZTA
Gilbert Cisneros purchase AZTA on Jan 15, 2026 (amount: $15.00K).
Gilbert Cisneros purchase AZTA on Oct 9, 2025 (amount: $15.00K).
Josh Gottheimer sale AZTA on Mar 19, 2025 (amount: $15.00K).
Recent politician trading activity in AZTA includes disclosures from Gilbert Cisneros, Gilbert Cisneros, and Josh Gottheimer. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in AZTA?
Yes. Rallies tracks politician and congressional stock disclosures for AZTA, including reported purchases, sales, dates, owners, and trade amounts when available.
Is AZTA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AZTA. It does not provide personalized investment advice.
